Sandoz conducting recall of methotrexate sodium

  • May 21, 2013

Sandoz is conducting a voluntary, nationwide recall of two lots of its methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable drug because it discovered particulate matter in some vials, the FDA announced today.

“Parenteral injection … from affected lots can lead to microembolization in areas where the particles lodge,” a press release stated. Sandoz discovered the issue during a routine quality examination of retention samples. Sandoz is unaware of any related adverse events, and clinical symptoms were not expected from the microemboli, according to the manufacturer.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Fibromyalgia
  • Bruno Gualano, PhD
  • Creatine and muscle function
  • Supplementation increased muscle function, "but it had only a minor effect on general symptoms of fibromyalgia,” Bruno Gualano, PhD, said.
More »
  • Healio Minute, May 21, 2013
  • Healio Minute logo
  • First drink, new rule, best advice
  • Timing of first drink really matters, CMS floats trial “observation” balloon and healthy providers give best hypertension advice.
More »
More »
  • Genomics
  • Lionel B. Ivashkiv, MD
  • Focus on RA, Lupus
  • "We are very excited to try to understand how genes involved in lupus and rheumatoid arthritis are regulated," Lionel B. Ivashkiv said.
More »